Results 91 to 100 of about 868 (161)

Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines. [PDF]

Arq Bras Cardiol, 2020
Cesena FHY, Valente VA, Santos RD, Bittencourt MS.   +3 more
europepmc   +1 more source

Dislipidemia y nefropatía diabética

Bioquímica y Patología Clínica, 2007
La nefropatía diabética (ND) se asocia generalmente con dislipidemia que puede contribuir a una mayor morbimortalidad por complicaciones cardiovasculares. En este trabajo se compararon las características del perfil lipídico entre dos grupos de pacientes con diabetes mellitus tipo 2 de más de 5 años de evolución: grupo con Nefropatía Clínica ...
Cecilia Paparella, Griselda Della Rosa, Beatriz Bouvet, Adriana Monje, Sandra Arriaga, Adriana Almará   +5 more
openaire   +1 more source

INKT CELLS IN DISLIPIDEMIA.

, 2014
Natural killer T cells (NKT) are T lymphocytes with a reactivity directed against glycolipid antigens presented by MHC-like CD1d molecules expressed by antigen presenting cells (APC). A large proportion of these cells (invariant NKT cells (iNKT)) possess strong immunomodulatory properties which impose a profound impact on the development and course of ...
openaire   +1 more source

[Impact of COVID-19 on dyslipidemia in Ecuador]. [PDF]

Aten Primaria
Ferrés Font M, Salas R.
europepmc   +1 more source

Total cholesterol and low-density lipoprotein alterations in children and adolescents from Brazil: a prevalence meta-analysis. [PDF]

Arch Endocrinol Metab, 2023
da Silva TPR, Mendes LL, Barreto VMJ, Matozinhos FP, Duarte CK.   +4 more
europepmc   +1 more source

Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]

Arq Bras Cardiol
Rached FH, Miname MH, Rocha VZ, Zimerman A, Cesena FHY, Sposito AC, Santos RDD, Behr PEB, Bianco HT, Alves RJ, Faludi AA, Coutinho EDR, Fonseca FAH, Carvalho LSF, Bertolami A, Rocha AMD, Marte AP, Chagas ACP, Caramelli B, Polanczyk CA, Ferreira CEDS, Serrano Junior CV, Araujo DB, Moriguchi EH, Pinto FJ, Moreira HG, Back IC, Faria Neto JR, Maia KAP, Bertolami MC, Assad MHV, Izar MCO, Barreto MA, Barreto NSF, Silva PGMBE, Pimentel Filho P, Maranhão RC, Kaiser SE, Machado VA, Saraiva JFK.   +39 more
europepmc   +1 more source

Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022. [PDF]

Aten Primaria
Rivadeneira J, Fuenmayor-González L, Jácome-García M, Flores-Lastra N, Delgado H, Otzen T.   +5 more
europepmc   +1 more source

[Omega-3 polyunsaturated fatty acids in pediatric patients with acute lymphoblastic leukemia]. [PDF]

Rev Med Inst Mex Seguro Soc
Morales-Montes SB, Atilano-Miguel S, Barbosa-Cortés ML.   +2 more
europepmc   +1 more source

Dislipidemias, ¿qué hay de nuevo?

Revista del Hospital Italiano de Buenos Aires
En los últimos años han surgido algunas investigaciones y guías de práctica clínica relacionadas con el diagnóstico y tratamiento de las dislipidemias, que aportaron nuevos conocimientos (y controversias) sobre dicha problemática.
Walter Masson
doaj  

Beyond Cholesterol and Triglycerides in the Lipid Clinic: The Challenging Task of Identifying Lysosomal Acid Lipase Deficiency. [PDF]

Arq Bras Cardiol
Mizuta MH, Santos RD.
europepmc   +1 more source